Published in J Clin Endocrinol Metab on January 08, 2010
Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med (2013) 2.65
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone. JAMA (2017) 2.29
A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging (2012) 2.24
Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med (2013) 2.05
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care (2011) 1.91
Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov (2015) 1.90
Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract (2013) 1.71
Measures of frailty in population-based studies: an overview. BMC Geriatr (2013) 1.69
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care (2011) 1.60
Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc (2010) 1.51
Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle (2014) 1.50
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Genetic variant of Interleukin-18 gene is associated with the Frailty Index in the English Longitudinal Study of Ageing. Age Ageing (2015) 1.43
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013. JAMA (2017) 1.41
Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab (2011) 1.33
Optimal management of sarcopenia. Clin Interv Aging (2010) 1.29
Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy. Ann Pharmacother (2014) 1.25
Are we closer to having drugs to treat muscle wasting disease? J Cachexia Sarcopenia Muscle (2014) 1.22
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci (2013) 1.17
Difference in muscle quality over the adult life span and biological correlates in the Baltimore Longitudinal Study of Aging. J Am Geriatr Soc (2014) 1.09
Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl (2014) 1.05
Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol (2011) 1.03
Aging and declining testosterone: past, present, and hopes for the future. J Androl (2012) 1.01
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diabetes Rev (2012) 1.00
Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab (2011) 0.99
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci (2012) 0.96
Sarcopenia: designing phase IIB trials. J Nutr Health Aging (2011) 0.94
The frailty syndrome in general practitioner care: a pilot study. Z Gerontol Geriatr (2010) 0.93
Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology (2014) 0.93
Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes (2013) 0.92
Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels. J Clin Endocrinol Metab (2013) 0.92
Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab (2014) 0.92
Hematological changes during androgen deprivation therapy. Asian J Androl (2012) 0.91
Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl (2014) 0.91
Treatment of Men for "Low Testosterone": A Systematic Review. PLoS One (2016) 0.90
Testosterone deficiency and cardiovascular mortality. Asian J Androl (2015) 0.90
Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity. J Lipid Res (2012) 0.87
The role of hypogonadism in Klinefelter syndrome. Asian J Androl (2014) 0.86
Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes (2012) 0.86
Mitochondrial and sex steroid hormone crosstalk during aging. Longev Healthspan (2014) 0.86
Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis. BMC Med (2014) 0.85
Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging. PLoS One (2012) 0.85
Validating a widely used measure of frailty: are all sub-components necessary? Evidence from the Whitehall II cohort study. Age (Dordr) (2012) 0.84
The treatment of late-onset hypogonadism. Turk J Urol (2014) 0.84
Human androgen deficiency: insights gained from androgen receptor knockout mouse models. Asian J Androl (2014) 0.84
Therapies for musculoskeletal disease: can we treat two birds with one stone? Curr Osteoporos Rep (2014) 0.83
Androgen effects on skeletal muscle: implications for the development and management of frailty. Asian J Androl (2014) 0.83
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging (2012) 0.83
Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male (2012) 0.83
Sex steroids and cardiovascular disease. Asian J Androl (2014) 0.82
Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons. Curr Pharm Des (2014) 0.82
Testosterone therapy and mortality risk. Int J Impot Res (2014) 0.82
Off-label use of hormones as an antiaging strategy: a review. Clin Interv Aging (2014) 0.82
Gonadal status and physical performance in older men. Aging Male (2010) 0.81
Testosterone and weight loss: the evidence. Curr Opin Endocrinol Diabetes Obes (2014) 0.80
Androgens and prostate disease. Asian J Androl (2014) 0.80
Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial. BMC Med (2016) 0.80
Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults. Int J Endocrinol (2014) 0.80
An update on male hypogonadism therapy. Expert Opin Pharmacother (2014) 0.80
Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology. J Endocrinol Invest (2014) 0.80
Frailty and sarcopenia in elderly. Wien Klin Wochenschr (2016) 0.80
Diagnosis and treatment of hypogonadism in older men: proceed with caution. Asian J Androl (2010) 0.79
A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male (2013) 0.79
Testosterone replacement alters the cell size in visceral fat but not in subcutaneous fat in hypogonadal aged male rats as a late-onset hypogonadism animal model. Res Rep Urol (2015) 0.79
Male hormonal contraception: hope and promise. Lancet Diabetes Endocrinol (2016) 0.78
Diagnosis and Treatment of Low Testosterone among Patients with End-Stage Renal Disease. Semin Dial (2014) 0.78
Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes (2014) 0.78
Androgens and male aging: Current evidence of safety and efficacy. Asian J Androl (2010) 0.77
Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy. Aging Cell (2013) 0.77
Testosterone, HDL and cardiovascular risk in men: the jury is still out. Clin Lipidol (2012) 0.77
Relationship between Serum Testosterone and Cardiovascular Disease Risk Determined Using the Framingham Risk Score in Male Patients with Sexual Dysfunction. World J Mens Health (2014) 0.77
Testosterone treatment of older men--why are controversies created? J Clin Endocrinol Metab (2011) 0.77
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study. Vasc Health Risk Manag (2016) 0.77
More than osteoporosis: age-specific issues in bone health. Curr Opin HIV AIDS (2016) 0.76
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab (2016) 0.76
Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications. J Clin Endocrinol Metab (2015) 0.76
Effects of Saikokaryukotsuboreito on Spermatogenesis and Fertility in Aging Male Mice. Chin Med J (Engl) (2016) 0.76
Testosterone deficiency and treatment in older men: definition, treatment, pitfalls. Asian J Androl (2010) 0.76
International web survey shows high prevalence of symptomatic testosterone deficiency in men. Aging Male (2010) 0.76
Resistance Training for Glycemic Control, Muscular Strength, and Lean Body Mass in Old Type 2 Diabetic Patients: A Meta-Analysis. Diabetes Ther (2017) 0.76
Testosterone deficiency in the aging male. Ther Adv Urol (2016) 0.75
Effects of Testosterone Supplementation for 3-Years on Muscle Performance and Physical Function in Older Men. J Clin Endocrinol Metab (2016) 0.75
An update on the role of testosterone replacement therapy in the management of hypogonadism. Ther Adv Urol (2015) 0.75
Testosterone replacement and cardiovascular safety: no straight and narrow! Clin Med Insights Cardiol (2015) 0.75
Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Investig Clin Urol (2016) 0.75
Association between body fat distribution and androgen deficiency in middle-aged and elderly men in China. Int J Impot Res (2013) 0.75
Effects of velvet antler polypeptide on sexual behavior and testosterone synthesis in aging male mice. Asian J Androl (2016) 0.75
Androgen Therapy and Rehospitalization in Older Men With Testosterone Deficiency. Mayo Clin Proc (2016) 0.75
Re: Effects of Testosterone Treatment in Older Men. Eur Urol (2016) 0.75
Efficacy and safety of testosterone replacement therapy in men with hypogonadism: A meta-analysis study of placebo-controlled trials. Exp Ther Med (2015) 0.75
An update on testosterone, HDL and cardiovascular risk in men. Clin Lipidol (2015) 0.75
Pulmonary rehabilitation: the reference therapy for undernourished patients with chronic obstructive pulmonary disease. Biomed Res Int (2014) 0.75
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ (2008) 3.32
Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine (2006) 3.18
Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys (2011) 2.86
Design and analysis of clinical trials with clustering effects due to treatment. Clin Trials (2005) 2.62
Association of hypogonadism with vitamin D status: the European Male Ageing Study. Eur J Endocrinol (2011) 2.28
Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom (2008) 2.21
Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels. FASEB J (2013) 2.16
Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing (2005) 2.07
Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab (2010) 2.01
Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol (2008) 1.99
Vitamin D status and muscle function in post-menarchal adolescent girls. J Clin Endocrinol Metab (2008) 1.86
Female genital injuries resulting from consensual and non-consensual vaginal intercourse. Forensic Sci Int (2010) 1.85
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int (2013) 1.84
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis (2010) 1.83
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230). J Bone Miner Res (2006) 1.80
Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod (2012) 1.78
Where do people die? An international comparison of the percentage of deaths occurring in hospital and residential aged care settings in 45 populations, using published and available statistics. Int J Public Health (2012) 1.72
Vitamin D status and bone mass in UK South Asian women. Bone (2006) 1.72
Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol (2006) 1.65
Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. Eur J Endocrinol (2012) 1.65
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril (2008) 1.64
Frailty and sexual health in older European men. J Gerontol A Biol Sci Med Sci (2012) 1.58
Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatr Soc (2011) 1.57
Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? J Clin Endocrinol Metab (2010) 1.54
The relationships between sex hormones and sexual function in middle-aged and older European men. J Clin Endocrinol Metab (2011) 1.53
Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists. Clin Endocrinol (Oxf) (2014) 1.52
Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists. Hum Fertil (Camb) (2008) 1.46
Radiographic features of lumbar disc degeneration and self-reported back pain. J Rheumatol (2004) 1.46
Genetic determinants of serum testosterone concentrations in men. PLoS Genet (2011) 1.45
Life and living in advanced age: a cohort study in New Zealand--e Puāwaitanga o Nga Tapuwae Kia Ora Tonu, LiLACS NZ: study protocol. BMC Geriatr (2012) 1.45
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry (2009) 1.44
A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health (2007) 1.44
HealthPathways website: making the right thing the easy thing to do? N Z Med J (2015) 1.42
Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men. Pain (2011) 1.41
Audit of acute exacerbations of chronic obstructive pulmonary disease at Waitemata District Health Board, New Zealand. N Z Med J (2013) 1.40
Do gerontology nurse specialists make a difference in hospitalization of long-term care residents? Results of a randomized comparison trial. J Am Geriatr Soc (2014) 1.39
Informing adolescents about human papillomavirus vaccination: what will parents allow? Vaccine (2008) 1.37
Pulmonary rehabilitation programmes in the UK: a national representative survey. Clin Rehabil (2004) 1.36
The European Male Ageing Study (EMAS): design, methods and recruitment. Int J Androl (2008) 1.33
Impaired tamoxifen metabolism reduces survival in familial breast cancer patients. Clin Cancer Res (2008) 1.28
Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med (2009) 1.28
Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin Cancer Res (2004) 1.27
Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation. Oral Oncol (2006) 1.25
Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur Radiol (2010) 1.22
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol (2008) 1.21
Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Womens Health (2009) 1.21
Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. J Clin Endocrinol Metab (2008) 1.19
The ability of three different models of frailty to predict all-cause mortality: results from the European Male Aging Study (EMAS). Arch Gerontol Geriatr (2013) 1.18
Goal setting as a feature of homecare services for older people: does it make a difference? Age Ageing (2011) 1.17
A comprehensive survey of wearable and wireless ECG monitoring systems for older adults. Med Biol Eng Comput (2013) 1.16
Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol (2009) 1.14
Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann Rheum Dis (2010) 1.14
UK reference data for the Hologic QDR Discovery dual-energy x ray absorptiometry scanner in healthy children and young adults aged 6-17 years. Arch Dis Child (2006) 1.12
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2009) 1.11
Valuing pharmacogenetic testing services: a comparison of patients' and health care professionals' preferences. Value Health (2011) 1.10
Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab (2012) 1.08
The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod (2009) 1.07
Under-reporting of osteoporotic vertebral fractures on computed tomography. Eur J Radiol (2007) 1.06
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab (2008) 1.05
Clinical disorders in a post war British cohort reaching retirement: evidence from the First National Birth Cohort study. PLoS One (2012) 1.05
Influence of weight, body mass index and lifestyle factors on radiographic features of lumbar disc degeneration. Ann Rheum Dis (2007) 1.03
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients. Breast Cancer Res Treat (2012) 1.00
Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men. J Bone Miner Res (2010) 1.00
Evaluation of a primary care musculoskeletal clinical assessment service: a preliminary study. Physiotherapy (2010) 0.99
Lumbar disc degeneration: association between osteophytes, end-plate sclerosis and disc space narrowing. Ann Rheum Dis (2006) 0.99
Growth from birth to adulthood and bone phenotype in early old age: a British birth cohort study. J Bone Miner Res (2014) 0.99
Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. Eur J Endocrinol (2011) 0.98
Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). J Clin Endocrinol Metab (2013) 0.98
TGF-beta1 in chronic allograft nephropathy following renal transplantation. J Nephrol (2007) 0.97
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol (2013) 0.97
Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry (2003) 0.97
Ethnic differences in aortic pulse wave velocity occur in the descending aorta and may be related to vitamin D. Hypertension (2011) 0.97
Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men. J Clin Endocrinol Metab (2013) 0.97
Predictors of poor perinatal outcome following maternal perception of reduced fetal movements--a prospective cohort study. PLoS One (2012) 0.97
Radiologic assessment of osteoporotic vertebral fractures: diagnostic and prognostic implications. Eur Radiol (2005) 0.97
Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake. J Epidemiol Community Health (2014) 0.96
The school nurse, the school and HPV vaccination: a qualitative study of factors affecting HPV vaccine uptake. Vaccine (2011) 0.96
No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain. Ann Rheum Dis (2010) 0.96
Cohort profile: the European Male Ageing Study. Int J Epidemiol (2012) 0.95
Age-related differences in smoking cessation advice and support given to patients hospitalised with smoking-related illness. Age Ageing (2005) 0.94
Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab (2004) 0.93
UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan. Pharmacogenomics (2009) 0.92
PLAUR polymorphisms and lung function in UK smokers. BMC Med Genet (2009) 0.91
Vertebral morphometry: semiautomatic determination of detailed shape from dual-energy X-ray absorptiometry images using active appearance models. Invest Radiol (2006) 0.91
The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.90
Breast cancer susceptibility variants alter risks in familial disease. J Med Genet (2009) 0.90
The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability. Fertil Steril (2010) 0.90
Mobile healthcare applications: system design review, critical issues and challenges. Australas Phys Eng Sci Med (2014) 0.90